iLABMED (iLABMED)

Publisher : Shenzhen Third People's Hospital & Tsinghua University Press (TUP)

Molecular Pathology Intelligent Medicine Evidence-Based Laboratory Medicine

Claim Your Journal Get PRC Visit Website

e-ISSN 2834-4448

p-ISSN 2834-443X

Issue Frequency Quarterly

Est. Year 2023

Mobile 861083470373

DOI YES

Language English

APC YES

Impact Factor Assignee Google Scholar

Email ilabmed@tup.tsinghua.edu.cn

Journal Descriptions

iLABMED presents the latest developments in the clinical laboratory sciences. We cover key topics in all aspects of laboratory medicine and related multidisciplinary research. Focusing on computer and data science enabled intelligent medicine, we unite researchers and clinicians from diverse medical subspecialities, including artificial intelligence, bioinformatics, proteomics, materials and more, to enable collaboration and further advance the field. iLABMED is a high-quality, peer-reviewed, open access journal covering key topics in all aspects of laboratory medicine and related multidisciplinary research, focusing on the computer and data science enabled intelligent medicine, basic science，clinical research，and translational application in laboratory medicine and other emerging interdisciplinary, strategic frontiers and key common technologies in laboratory medicine and related multidisciplinary. The journal aims to provide a platform for the researchers, scholars, administrators, and innovators to share their research achievements in the basic and applied research and frontier clinical laboratory medicine on a scientific basis. The journal is committed to publishing the highest-quality and up-to-date research, promoting the development of health prevention and diagnosis and treatment research.

iLABMED (iLABMED) is :-

International, Peer-Reviewed, Open Access, Refereed, Molecular Pathology, Intelligent Medicine, Evidence-Based Laboratory Medicine, Clinical Biochemistry, Clinical Genomics, Molecular Biology, Clinical Hematology, Transfusion Medicine, Clinical Immunology, Autoimmunity, Clinical Microbiology, Drug Monitoring, Drug Analysis, Diagnostic Biomarkers, Public Health Screening, Disease Markers, Cardiovascular Disease, Cancer Diagnostics, Diabetes Monitoring, New Reagents, Instrumentation, Technologies, Methodologies, Reference Materials, Reference Methods, Reference Values, Decision Limits, Quality, Safety, Translational Laboratory Medicine, Bioinformatics , Online or Print , Quarterly Journal
UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2834-443X, E-ISSN: 2834-4448, Established: 2023,
Provides Crossref DOI
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE